Fermenta Biotech Share Price Target 2025, 2026, 2030, 2040, 2050

Fermenta Biotech is an Indian company that is known for making Vitamin D3 medicines. This vitamin is used in medicines, health supplements, food, animal feed, and products to control pests. Besides Vitamin D3, it also makes special ingredients for medicines and enzymes that help in making antibiotics. The company also helps treat and manage dirty water through its environmental services. With advanced factories and a research centre, it provides products and services to many industries. It also cares about the environment and follows the environmental steps to pollute as little as less it can.

What is Fermenta Biotech Ltd NSE: FERMENTA?

Fermenta Biotech was established in 1951, situated in Thane, Maharashtra. It is known around the world for making Vitamin D3, which it sells to over 60 countries. The company also makes special chemicals used in medicines, called Active Pharmaceutical Ingredients. It creates helpful enzymes that are used to make antibiotics and other products. Besides this, the company also works on projects that help clean dirty water and manage waste. Since 2012, it has also been building office spaces. The company has branches in the United States and Germany, and one of its factories in Gujarat follows high European quality standards.

Share Price Target Tomorrow

The stock has gradually fallen in some past months. The stock was at its all-time high price and then made a range, and finally it fell. Now the stock is slowly showing a bullish move, which is a good sign, but what intensity it showed during the fall should be considered, and one should wait for multiple confirmations to buy the stock.

Day	Minimum Price (Rs)	Maximum Price (Rs)
Tomorrow	-14	+24

Fermenta Biotech share price Target 2025

It is a well-known company that works in making medicines, using science to solve problems, and in real estate. Its goal is to make high-quality products that are used in making medicines, food, and other chemicals. It uses smart and focused research to become a top eco-friendly company in its field. The company is learning from its past, doing its best, and getting good results. It was started by Dr. DVK Raju, a smart and hardworking man from a village in Andhra Pradesh. After studying pharmacy in London, he came back to India and started the company with great passion. In 2025, its share price target would be ₹600, as per our analysis.

By our prediction, its share price would be between ₹219 to ₹600 in 2025.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	219	600

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	341	435
February	219	449
March	220	300
April	241	313
May	252	315
June	235	432
July	261	455
August	289	478
September	374	500
October	400	537
November	471	574
December	522	600

Fermenta Biotech Share Price Target 2026

It sells its products to many countries through a wide network. The company has a modern research centre in Thane and factories in Kullu, Himachal Pradesh, and Dahej, Gujarat. Along with Vitamin D3, it also makes special medicines, helpful enzymes used to make antibiotics, and services to treat and clean dirty water. It believes in doing business responsibly, meeting customer needs with new ideas, always working to do better, supporting its employees, and being honest and trustworthy in everything it does. In 2026, its share price target would be ₹960, as per our prediction.

Its share price would be between ₹522 to ₹960 in 2026, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	522	960

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	522	634
February	547	674
March	577	700
April	612	722
May	632	742
June	622	768
July	658	788
August	684	800
September	714	834
October	751	859
November	784	900
December	852	960

Share price Target 2027

It offers Vitamin D3 in different forms, like powder, oil, and types that mix easily with water. These can be used in things like injections, soft gel capsules, vitamin mixes, and for adding vitamins to food and drinks. Besides Vitamin D3, it also makes Vitamin K1 in two forms, one for making medicines and one as a spray-dried powder, and Vitamin E50. The company also produces some special medicines like Phenvramidol and silicon dig. In 2027, its share price target would be ₹1300, as per our analysis.

By our prediction, its share price would be between ₹852 to ₹1300 in 2027.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	852	1300

Share price Target 2028

Its products are used as injections, soft gel capsules, vitamin mixes, and for adding vitamins to food and drinks. It was the first company in India to use its special method to make Vitamin D3. With many years of experience, it now works with over 350 customers and is one of the top three Vitamin D3 producers in the world. The cholesterol used to make the vitamin comes from sheep wool, which is safely collected from countries without certain animal diseases. In 2028, its share price target would be ₹1663, as per our prediction.

Its share price would be between ₹1219 to ₹1663 in 2028, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	1219	1663

Share price Target 2029

Many people around the world don’t get enough important vitamins and minerals, which can lead to poor health, trouble learning, and low energy to work. Good nutrition is important for a healthy life and a better future. It helps mothers and children stay healthy, makes the immune system stronger, and lowers the risk of illness for everyone. The company’s product is a safe, low-cost way to improve health without changing what people normally eat, and it also helps food companies offer better products. In 2029, its share price target would be ₹2000, as per our analysis.

By our prediction, its share price would be between ₹1522 to ₹2000 in 2029.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	1522	2000

Fermenta Biotech share price Target 2030

It involves a special enzyme that helps in making medicines at different stages. These enzymes are very useful for making common antibiotics like Amoxicillin, Ampicillin, Cephalexin, and Cefadroxil. It produces enzymes such as Fermentase PS 250 and Penicillin G Acylase, which are used in the process of making these antibiotics. These technologies help make medicine in a better, faster, and more eco-friendly way. In 2030, its share price target would be ₹2360, as per our prediction.

Its share price would be between ₹1891 to ₹2360 in 2030, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	1891	2360

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1891	2039
February	1947	2062
March	1982	2090
April	2000	2124
May	2029	2147
June	2044	2165
July	2063	2184
August	2078	2200
September	2094	2232
October	2121	2274
November	2157	2290
December	2212	2360

Share price Target 2040

It offers simple and effective services to help protect the environment, especially by reusing water. Along with its biotech products, the company builds and runs plants that clean sewage, drinking water, and industrial waste. They handle everything from planning and design to building these plants. It uses modern methods like special filters and treatment systems to make dirty water clean and safe to use again, helping save water and care for nature. In 2040, its share price target would be ₹4870, as per our analysis.

By our prediction, its share price would be between ₹4440 to ₹4870 in 2040.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	4440	4870

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	4440	4589
February	4474	4632
March	4490	4678
April	4537	4700
May	4575	4732
June	4590	4761
July	4634	4785
August	4665	4800
September	4689	4839
October	4732	4878
November	4785	4900
December	4825	4947

Share Price Target 2050

It has also started working in real estate with a project called Thane One, a modern office building in a good area of Thane. The building has about 200,000 square feet of office space, which is fully rented, and there is some extra land too. Many well-known companies have offices there. The building has offices, banquet halls, meeting rooms, and guest rooms. It was built in an eco-friendly way and has its own system to clean and reuse water. Thane One has also won awards for its design and green features. In 2050, its share price target would be ₹7791, as per our prediction.

Its share price would be between ₹7275 to ₹7791 in 2050, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	7275	7791

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	7275	7411
February	7314	7429
March	7325	7441
April	7354	7474
May	7384	7522
June	7425	7545
July	7458	7588
August	7478	7625
September	7500	7654
October	7524	7687
November	7567	7735
December	7588	7791

Should I buy Fermenta Biotech stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	219	600
2026	522	960
2027	852	1300
2028	1219	1663
2029	1522	2000
2030	1891	2360
2040	4440	4870
2050	7275	7791

The company has done well, its profits have gone up, and the owners have bought more shares, which shows they believe in the company. It also sells to over 60 countries and has good factories and research labs. But there are some things to be careful about. In the last few years, its sales have not grown much, the profit made from each rupee invested is low, and the stock price is a bit high compared to the value of the company. So, while the company has potential and is improving, it may be better to wait and see if the growth continues before buying the stock for the long term.

Fermenta Biotech earnings results

	Mar 2020	Mar 2021	Mar 2022	Mar 2023		Mar 2024		Mar 2025
Sales +	292	376	397	349		335		469
Expenses +	225	293	335	330		307		360
Operating Profit	66	83	62	18		28		110
OPM %	23%	22%	16%	5%		8%		23%
Other Income +	12	8	8	-20		4		12
Interest	20	19	18	21		17		14
Depreciation	15	20	26	28		25		24
Profit before tax	43	52	27	-51		-10		83
Tax %	-37%	18%	44%	4%		143%		8%
Net Profit +	60	43	15	-53		-24		76
EPS in Rs	20.23	15.46	5.25	-17.36		-7.84		26.12
Dividend Payout %	24%	16%	23%	-7%		-16%		0%
Dividend Payout %		0%	0%	0%	44%		0%	0%

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
11.84	3.19	—	35.18	6.49	0.86%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
Fermenta Biotech Ltd	11.84	3.19	—
Sun Pharmaceutical Industries Ltd	36.83	6.00	0.95%
Cipla Ltd	22.45	4.42	1.09%
Torrent Pharmaceuticals Ltd	56.23	15.67	1.01%

Is Fermenta Biotech stock good to buy? (bull case & bear case)

Bull Case:

• Sales grew by 58% compared to last year.
• Profits before tax also increased by more than double.
• Net profit jumped by almost 3 times compared to last year.
• Earnings per share are much better now at ₹12.71.
• There’s strong demand for its products in the health and animal sectors.
• The stock price recently hit a yearly high, showing strong interest.
• The stock is still reasonably priced compared to its earnings.
• Company promoters increased their shareholding by 2.03%, which is a good sign.

Bear Case:

• Over the last 5 years, profits have been shrinking.
• The stock is a bit expensive, it’s priced 2.5 times more than its book value.
• Sales have grown very slowly, only about 10% in 5 years.
• Return on equity is low at just 3.55%, meaning it’s not generating much profit from shareholders’ money.

Conclusion

It makes Vitamin D3 and other useful products for medicines, food, and cleaning dirty water. It also builds office spaces and tries to protect the environment by using safe and smart methods. The company sells its products in many countries and has good factories and labs. Recently, it has been making more profit, and the owners have bought more shares, which is a good sign.

FAQs